ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
hsa04066	HIF-1 signaling pathway	4/22	109/8144	0.00018444579160921	0.0188708122191643	0.0148098557434737	PFKP/BCL2/PRKCA/VHL	4
hsa05417	Lipid and atherosclerosis	5/22	215/8144	0.000223323221528572	0.0188708122191643	0.0148098557434737	FOS/ERO1A/BCL2/DDIT3/PRKCA	5
hsa05161	Hepatitis B	4/22	162/8144	0.000834249754946145	0.0397419343778341	0.0311895592127505	FOS/TGFB3/BCL2/PRKCA	4
hsa04010	MAPK signaling pathway	5/22	294/8144	0.000940637500067079	0.0397419343778341	0.0311895592127505	FOS/DUSP1/TGFB3/DDIT3/PRKCA	5
hsa05210	Colorectal cancer	3/22	86/8144	0.00151449351326693	0.0511898807484223	0.0401739331940281	FOS/TGFB3/BCL2	3
hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	2/22	24/8144	0.00185476277574543	0.052242484850163	0.0410000192533201	NDST1/EXT1	2
hsa04933	AGE-RAGE signaling pathway in diabetic complications	3/22	100/8144	0.00233507836086653	0.0558571395216588	0.0438368083446216	TGFB3/BCL2/PRKCA	3
hsa04928	Parathyroid hormone synthesis, secretion and action	3/22	106/8144	0.00275685519142301	0.0558571395216588	0.0438368083446216	FOS/BCL2/PRKCA	3
hsa00052	Galactose metabolism	2/22	31/8144	0.0030893282443029	0.0558571395216588	0.0438368083446216	PFKP/GAA	2
hsa04725	Cholinergic synapse	3/22	113/8144	0.00330515618471354	0.0558571395216588	0.0438368083446216	FOS/BCL2/PRKCA	3
hsa04935	Growth hormone synthesis, secretion and action	3/22	119/8144	0.00382502504303361	0.0584670122838617	0.0458850423404956	FOS/IRS2/PRKCA	3
hsa00500	Starch and sucrose metabolism	2/22	36/8144	0.00415150383080675	0.0584670122838617	0.0458850423404956	GAA/GBE1	2
hsa04270	Vascular smooth muscle contraction	3/22	134/8144	0.00533544395618021	0.06493222475482	0.0509589555845987	ADM/MYH9/PRKCA	3
hsa04210	Apoptosis	3/22	136/8144	0.00556033317271634	0.06493222475482	0.0509589555845987	FOS/BCL2/DDIT3	3
hsa05418	Fluid shear stress and atherosclerosis	3/22	139/8144	0.00590830202733793	0.06493222475482	0.0509589555845987	FOS/DUSP1/BCL2	3
hsa04140	Autophagy - animal	3/22	141/8144	0.00614742956258651	0.06493222475482	0.0509589555845987	RRAGD/IRS2/BCL2	3
hsa05110	Vibrio cholerae infection	2/22	50/8144	0.00789010498026491	0.0749680047098603	0.0588350581964646	ERO1A/PRKCA	2
hsa04932	Non-alcoholic fatty liver disease	3/22	155/8144	0.00798475789809163	0.0749680047098603	0.0588350581964646	FOS/IRS2/DDIT3	3
hsa04141	Protein processing in endoplasmic reticulum	3/22	171/8144	0.0104454107292	0.0929091796439367	0.072915332514083	ERO1A/BCL2/DDIT3	3
hsa05031	Amphetamine addiction	2/22	69/8144	0.0146501153922924	0.117898547680829	0.0925270445828993	FOS/PRKCA	2
hsa05211	Renal cell carcinoma	2/22	69/8144	0.0146501153922924	0.117898547680829	0.0925270445828993	TGFB3/VHL	2
hsa05415	Diabetic cardiomyopathy	3/22	203/8144	0.0165732931523609	0.123043969662787	0.0965651832918788	PDK3/TGFB3/PRKCA	3
hsa05140	Leishmaniasis	2/22	77/8144	0.0180360093112514	0.123043969662787	0.0965651832918788	FOS/TGFB3	2
hsa05170	Human immunodeficiency virus 1 infection	3/22	212/8144	0.0185948944000597	0.123043969662787	0.0965651832918788	FOS/BCL2/PRKCA	3
hsa05207	Chemical carcinogenesis - receptor activation	3/22	212/8144	0.0185948944000597	0.123043969662787	0.0965651832918788	FOS/BCL2/PRKCA	3
hsa01521	EGFR tyrosine kinase inhibitor resistance	2/22	79/8144	0.0189298414865826	0.123043969662787	0.0965651832918788	BCL2/PRKCA	2
hsa04658	Th1 and Th2 cell differentiation	2/22	92/8144	0.0251821383059642	0.154369935075695	0.121149871189895	FOS/RBPJ	2
hsa05323	Rheumatoid arthritis	2/22	93/8144	0.0256938996048294	0.154369935075695	0.121149871189895	FOS/TGFB3	2
hsa04713	Circadian entrainment	2/22	97/8144	0.0277834745997312	0.154369935075695	0.121149871189895	FOS/PRKCA	2
hsa01522	Endocrine resistance	2/22	98/8144	0.0283163786233524	0.154369935075695	0.121149871189895	FOS/BCL2	2
hsa05231	Choline metabolism in cancer	2/22	98/8144	0.0283163786233524	0.154369935075695	0.121149871189895	FOS/PRKCA	2
hsa05142	Chagas disease	2/22	102/8144	0.0304893095366252	0.156142221566353	0.122540765601747	FOS/TGFB3	2
hsa05146	Amoebiasis	2/22	102/8144	0.0304893095366252	0.156142221566353	0.122540765601747	TGFB3/PRKCA	2
hsa05145	Toxoplasmosis	2/22	112/8144	0.036202515501652	0.179947797640564	0.141223435083844	TGFB3/BCL2	2
hsa04726	Serotonergic synapse	2/22	115/8144	0.0379921374712602	0.183447749504085	0.143970205154249	DUSP1/PRKCA	2
hsa04071	Sphingolipid signaling pathway	2/22	119/8144	0.0404308007672494	0.185331747284561	0.14544877083684	BCL2/PRKCA	2
hsa04152	AMPK signaling pathway	2/22	120/8144	0.0410496913838022	0.185331747284561	0.14544877083684	PFKP/IRS2	2
hsa04919	Thyroid hormone signaling pathway	2/22	121/8144	0.0416722272000788	0.185331747284561	0.14544877083684	PFKP/PRKCA	2
hsa04926	Relaxin signaling pathway	2/22	129/8144	0.0467810930556242	0.19262647851706	0.151173692265023	FOS/PRKCA	2
hsa04068	FoxO signaling pathway	2/22	131/8144	0.0480932260505913	0.19262647851706	0.151173692265023	IRS2/TGFB3	2
hsa04142	Lysosome	2/22	132/8144	0.0487544113928138	0.19262647851706	0.151173692265023	GAA/IDS	2
hsa04728	Dopaminergic synapse	2/22	132/8144	0.0487544113928138	0.19262647851706	0.151173692265023	FOS/PRKCA	2
hsa05206	MicroRNAs in cancer	3/22	310/8144	0.0492540459923146	0.19262647851706	0.151173692265023	IRS2/BCL2/PRKCA	3
hsa00531	Glycosaminoglycan degradation	1/22	19/8144	0.0501512725133173	0.19262647851706	0.151173692265023	IDS	1
hsa04915	Estrogen signaling pathway	2/22	138/8144	0.0527918501450733	0.196467208135937	0.154187905481956	FOS/BCL2	2
hsa05162	Measles	2/22	139/8144	0.0534762815044563	0.196467208135937	0.154187905481956	FOS/BCL2	2
hsa05017	Spinocerebellar ataxia	2/22	143/8144	0.0562461731547195	0.202246877939311	0.158723803303352	RBPJ/PRKCA	2
hsa05226	Gastric cancer	2/22	149/8144	0.0604952599147201	0.211126448477887	0.165692510172617	TGFB3/BCL2	2
hsa04261	Adrenergic signaling in cardiomyocytes	2/22	150/8144	0.0612141773693281	0.211126448477887	0.165692510172617	BCL2/PRKCA	2
hsa04921	Oxytocin signaling pathway	2/22	154/8144	0.0641197918224982	0.216724896360044	0.17008618462389	FOS/PRKCA	2
hsa04150	mTOR signaling pathway	2/22	156/8144	0.0655902903545724	0.217348217057309	0.17057536810477	RRAGD/PRKCA	2
hsa05225	Hepatocellular carcinoma	2/22	168/8144	0.0746512227952069	0.242616474084422	0.190405952878463	TGFB3/PRKCA	2
hsa00030	Pentose phosphate pathway	1/22	30/8144	0.0780791895799265	0.24896949130203	0.195391815036162	PFKP	1
hsa04215	Apoptosis - multiple species	1/22	32/8144	0.0830720434479727	0.258204178383221	0.202639218164346	BCL2	1
hsa05152	Tuberculosis	2/22	180/8144	0.0840966343839438	0.258204178383221	0.202639218164346	TGFB3/BCL2	2
hsa00051	Fructose and mannose metabolism	1/22	33/8144	0.0855587810027241	0.258204178383221	0.202639218164346	PFKP	1
hsa04960	Aldosterone-regulated sodium reabsorption	1/22	37/8144	0.0954415062722779	0.278096802758879	0.218250994379438	PRKCA	1
hsa05143	African trypanosomiasis	1/22	37/8144	0.0954415062722779	0.278096802758879	0.218250994379438	PRKCA	1
hsa05130	Pathogenic Escherichia coli infection	2/22	197/8144	0.0980751623248351	0.280927159879612	0.220472264994277	FOS/MYH9	2
hsa04510	Focal adhesion	2/22	201/8144	0.101458085193263	0.283446516336683	0.222449461590919	BCL2/PRKCA	2
hsa05169	Epstein-Barr virus infection	2/22	202/8144	0.102309097612649	0.283446516336683	0.222449461590919	BCL2/RBPJ	2
hsa05205	Proteoglycans in cancer	2/22	205/8144	0.104874551327639	0.285867728618886	0.224349634419057	PRKCA/PLAUR	2
hsa04930	Type II diabetes mellitus	1/22	46/8144	0.117306221367843	0.314678593828022	0.246960466037563	IRS2	1
hsa05166	Human T-cell leukemia virus 1 infection	2/22	222/8144	0.119745089922673	0.316201878077057	0.248155942931854	FOS/TGFB3	2
hsa05144	Malaria	1/22	50/8144	0.126861094244596	0.329642627843825	0.258704273486901	TGFB3	1
hsa05171	Coronavirus disease - COVID-19	2/22	232/8144	0.128736174187529	0.329642627843825	0.258704273486901	FOS/PRKCA	2
hsa04961	Endocrine and other factor-regulated calcium reabsorption	1/22	53/8144	0.133962373955442	0.331957153796409	0.260520718644332	PRKCA	1
hsa05022	Pathways of neurodegeneration - multiple diseases	3/22	476/8144	0.134322563923032	0.331957153796409	0.260520718644332	BCL2/DDIT3/PRKCA	3
hsa04340	Hedgehog signaling pathway	1/22	56/8144	0.141008503453178	0.331957153796409	0.260520718644332	BCL2	1
hsa04923	Regulation of lipolysis in adipocytes	1/22	56/8144	0.141008503453178	0.331957153796409	0.260520718644332	IRS2	1
hsa05131	Shigellosis	2/22	247/8144	0.142522823220574	0.331957153796409	0.260520718644332	RRAGD/BCL2	2
hsa05132	Salmonella infection	2/22	249/8144	0.144386102999707	0.331957153796409	0.260520718644332	FOS/BCL2	2
hsa04330	Notch signaling pathway	1/22	59/8144	0.147999890802678	0.331957153796409	0.260520718644332	RBPJ	1
hsa04370	VEGF signaling pathway	1/22	59/8144	0.147999890802678	0.331957153796409	0.260520718644332	PRKCA	1
hsa04730	Long-term depression	1/22	60/8144	0.150318258446752	0.331957153796409	0.260520718644332	PRKCA	1
hsa04213	Longevity regulating pathway - multiple species	1/22	62/8144	0.154936941199387	0.331957153796409	0.260520718644332	IRS2	1
hsa04929	GnRH secretion	1/22	64/8144	0.159531653073544	0.331957153796409	0.260520718644332	PRKCA	1
hsa05012	Parkinson disease	2/22	266/8144	0.16043756942288	0.331957153796409	0.260520718644332	DUSP1/DDIT3	2
hsa05321	Inflammatory bowel disease	1/22	65/8144	0.161820056988443	0.331957153796409	0.260520718644332	TGFB3	1
hsa00010	Glycolysis / Gluconeogenesis	1/22	67/8144	0.166379034583619	0.331957153796409	0.260520718644332	PFKP	1
hsa04720	Long-term potentiation	1/22	67/8144	0.166379034583619	0.331957153796409	0.260520718644332	PRKCA	1
hsa04664	Fc epsilon RI signaling pathway	1/22	68/8144	0.168649637683676	0.331957153796409	0.260520718644332	PRKCA	1
hsa04920	Adipocytokine signaling pathway	1/22	69/8144	0.170914336540903	0.331957153796409	0.260520718644332	IRS2	1
hsa04917	Prolactin signaling pathway	1/22	70/8144	0.17317314577881	0.331957153796409	0.260520718644332	FOS	1
hsa05230	Central carbon metabolism in cancer	1/22	70/8144	0.17317314577881	0.331957153796409	0.260520718644332	PFKP	1
hsa05223	Non-small cell lung cancer	1/22	72/8144	0.177673153718728	0.331957153796409	0.260520718644332	PRKCA	1
hsa01524	Platinum drug resistance	1/22	73/8144	0.179914381496006	0.331957153796409	0.260520718644332	BCL2	1
hsa04115	p53 signaling pathway	1/22	73/8144	0.179914381496006	0.331957153796409	0.260520718644332	BCL2	1
hsa01230	Biosynthesis of amino acids	1/22	75/8144	0.184379357096883	0.331957153796409	0.260520718644332	PFKP	1
hsa04918	Thyroid hormone synthesis	1/22	75/8144	0.184379357096883	0.331957153796409	0.260520718644332	PRKCA	1
hsa05214	Glioma	1/22	75/8144	0.184379357096883	0.331957153796409	0.260520718644332	PRKCA	1
hsa04971	Gastric acid secretion	1/22	76/8144	0.186603133790881	0.331957153796409	0.260520718644332	PRKCA	1
hsa05133	Pertussis	1/22	76/8144	0.186603133790881	0.331957153796409	0.260520718644332	FOS	1
hsa05212	Pancreatic cancer	1/22	76/8144	0.186603133790881	0.331957153796409	0.260520718644332	TGFB3	1
hsa05220	Chronic myeloid leukemia	1/22	76/8144	0.186603133790881	0.331957153796409	0.260520718644332	TGFB3	1
hsa04060	Cytokine-cytokine receptor interaction	2/22	295/8144	0.188567992026787	0.331958235963823	0.260521567931745	TGFB3/ACKR3	2
hsa03018	RNA degradation	1/22	79/8144	0.193239791956458	0.334885461243788	0.262818860895156	PFKP	1
hsa04662	B cell receptor signaling pathway	1/22	82/8144	0.19982474254156	0.334885461243788	0.262818860895156	FOS	1
hsa04012	ErbB signaling pathway	1/22	85/8144	0.206358369369142	0.334885461243788	0.262818860895156	PRKCA	1
hsa04610	Complement and coagulation cascades	1/22	85/8144	0.206358369369142	0.334885461243788	0.262818860895156	PLAUR	1
hsa04911	Insulin secretion	1/22	86/8144	0.208524905648318	0.334885461243788	0.262818860895156	PRKCA	1
hsa04540	Gap junction	1/22	88/8144	0.212841053554508	0.334885461243788	0.262818860895156	PRKCA	1
hsa04211	Longevity regulating pathway	1/22	89/8144	0.214990693179856	0.334885461243788	0.262818860895156	IRS2	1
hsa04727	GABAergic synapse	1/22	89/8144	0.214990693179856	0.334885461243788	0.262818860895156	PRKCA	1
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/22	89/8144	0.214990693179856	0.334885461243788	0.262818860895156	FOS	1
hsa05410	Hypertrophic cardiomyopathy	1/22	90/8144	0.217134728530575	0.334885461243788	0.262818860895156	TGFB3	1
hsa05032	Morphine addiction	1/22	91/8144	0.219273173523414	0.334885461243788	0.262818860895156	PRKCA	1
hsa05222	Small cell lung cancer	1/22	92/8144	0.221406042042287	0.334885461243788	0.262818860895156	BCL2	1
hsa04912	GnRH signaling pathway	1/22	93/8144	0.223533347938347	0.334885461243788	0.262818860895156	PRKCA	1
hsa04970	Salivary secretion	1/22	93/8144	0.223533347938347	0.334885461243788	0.262818860895156	PRKCA	1
hsa04350	TGF-beta signaling pathway	1/22	94/8144	0.225655105030057	0.334885461243788	0.262818860895156	TGFB3	1
hsa04657	IL-17 signaling pathway	1/22	94/8144	0.225655105030057	0.334885461243788	0.262818860895156	FOS	1
hsa05414	Dilated cardiomyopathy	1/22	96/8144	0.229882027911283	0.334885461243788	0.262818860895156	TGFB3	1
hsa04070	Phosphatidylinositol signaling system	1/22	97/8144	0.231987221174945	0.334885461243788	0.262818860895156	PRKCA	1
hsa04666	Fc gamma R-mediated phagocytosis	1/22	97/8144	0.231987221174945	0.334885461243788	0.262818860895156	PRKCA	1
hsa05215	Prostate cancer	1/22	97/8144	0.231987221174945	0.334885461243788	0.262818860895156	BCL2	1
hsa04750	Inflammatory mediator regulation of TRP channels	1/22	98/8144	0.234086920582694	0.334885461243788	0.262818860895156	PRKCA	1
hsa04925	Aldosterone synthesis and secretion	1/22	98/8144	0.234086920582694	0.334885461243788	0.262818860895156	PRKCA	1
hsa04061	Viral protein interaction with cytokine and cytokine receptor	1/22	100/8144	0.238269892422666	0.334885461243788	0.262818860895156	ACKR3	1
hsa04916	Melanogenesis	1/22	101/8144	0.240353192070441	0.334885461243788	0.262818860895156	PRKCA	1
hsa04972	Pancreatic secretion	1/22	102/8144	0.242431052293548	0.334885461243788	0.262818860895156	PRKCA	1
hsa04064	NF-kappa B signaling pathway	1/22	104/8144	0.246570508543963	0.334885461243788	0.262818860895156	BCL2	1
hsa04620	Toll-like receptor signaling pathway	1/22	104/8144	0.246570508543963	0.334885461243788	0.262818860895156	FOS	1
hsa04660	T cell receptor signaling pathway	1/22	104/8144	0.246570508543963	0.334885461243788	0.262818860895156	FOS	1
hsa04151	PI3K-Akt signaling pathway	2/22	354/8144	0.247696347073807	0.334885461243788	0.262818860895156	BCL2/PRKCA	2
hsa04922	Glucagon signaling pathway	1/22	107/8144	0.252739234385797	0.336395478381981	0.264003925731109	PFKP	1
hsa04659	Th17 cell differentiation	1/22	108/8144	0.254784741023039	0.336395478381981	0.264003925731109	FOS	1
hsa04931	Insulin resistance	1/22	108/8144	0.254784741023039	0.336395478381981	0.264003925731109	IRS2	1
hsa05014	Amyotrophic lateral sclerosis	2/22	364/8144	0.257859320675328	0.337815699179306	0.2651185181974	BCL2/DDIT3	2
hsa04668	TNF signaling pathway	1/22	112/8144	0.262913446461454	0.341754035328646	0.268209333238302	FOS	1
hsa04670	Leukocyte transendothelial migration	1/22	114/8144	0.26694599201881	0.341754035328646	0.268209333238302	PRKCA	1
hsa04724	Glutamatergic synapse	1/22	114/8144	0.26694599201881	0.341754035328646	0.268209333238302	PRKCA	1
hsa01200	Carbon metabolism	1/22	115/8144	0.268954359163964	0.341754035328646	0.268209333238302	PFKP	1
hsa04722	Neurotrophin signaling pathway	1/22	119/8144	0.276935429235649	0.348304710630591	0.273350317903796	BCL2	1
hsa05010	Alzheimer disease	2/22	384/8144	0.27823157358065	0.348304710630591	0.273350317903796	IRS2/DDIT3	2
hsa04110	Cell cycle	1/22	126/8144	0.290702568666588	0.361240691945981	0.283502505046363	TGFB3	1
hsa04380	Osteoclast differentiation	1/22	128/8144	0.294589848775285	0.363399156518417	0.285196472882719	FOS	1
hsa04650	Natural killer cell mediated cytotoxicity	1/22	131/8144	0.300382661632916	0.367859926202629	0.288697294933237	PRKCA	1
hsa04910	Insulin signaling pathway	1/22	137/8144	0.311832351339407	0.376426195545427	0.295420122321543	IRS2	1
hsa05135	Yersinia infection	1/22	137/8144	0.311832351339407	0.376426195545427	0.295420122321543	FOS	1
hsa04120	Ubiquitin mediated proteolysis	1/22	142/8144	0.321236911521128	0.385028638631706	0.302171338944846	VHL	1
hsa05224	Breast cancer	1/22	147/8144	0.330518713785526	0.390061949856445	0.306121492880175	FOS	1
hsa04072	Phospholipase D signaling pathway	1/22	148/8144	0.33236047798419	0.390061949856445	0.306121492880175	PRKCA	1
hsa04723	Retrograde endocannabinoid signaling	1/22	148/8144	0.33236047798419	0.390061949856445	0.306121492880175	PRKCA	1
hsa04218	Cellular senescence	1/22	156/8144	0.346921470589953	0.403655498202447	0.316789740102823	TGFB3	1
hsa04390	Hippo signaling pathway	1/22	157/8144	0.348720134541759	0.403655498202447	0.316789740102823	TGFB3	1
hsa04217	Necroptosis	1/22	159/8144	0.352303286755678	0.405028948719113	0.31786762714798	BCL2	1
hsa04630	JAK-STAT signaling pathway	1/22	162/8144	0.35764275308505	0.408389359941712	0.3205048854105	BCL2	1
hsa04022	cGMP-PKG signaling pathway	1/22	167/8144	0.366448614216579	0.412865438684013	0.324017722044133	IRS2	1
hsa04310	Wnt signaling pathway	1/22	167/8144	0.366448614216579	0.412865438684013	0.324017722044133	PRKCA	1
hsa04530	Tight junction	1/22	169/8144	0.369938593317605	0.414037233580631	0.324937349306506	MYH9	1
hsa05164	Influenza A	1/22	171/8144	0.373410216791907	0.415173201564686	0.325828859527565	PRKCA	1
hsa04360	Axon guidance	1/22	182/8144	0.392180126934403	0.433192427790289	0.339970388673786	PRKCA	1
hsa04621	NOD-like receptor signaling pathway	1/22	184/8144	0.395534661078919	0.434060764430761	0.340651861216294	BCL2	1
hsa04613	Neutrophil extracellular trap formation	1/22	190/8144	0.405492559289897	0.442117693677371	0.346974957355022	PRKCA	1
hsa05202	Transcriptional misregulation in cancer	1/22	193/8144	0.410412595855327	0.443537758627273	0.348089427511905	DDIT3	1
hsa05167	Kaposi sarcoma-associated herpesvirus infection	1/22	194/8144	0.412043953280957	0.443537758627273	0.348089427511905	FOS	1
hsa05203	Viral carcinogenesis	1/22	204/8144	0.428122299448138	0.457928282321109	0.359383142774586	RBPJ	1
hsa04015	Rap1 signaling pathway	1/22	210/8144	0.437566926025327	0.465086858479751	0.365001209395507	PRKCA	1
hsa04810	Regulation of actin cytoskeleton	1/22	218/8144	0.449928370050405	0.47523684086574	0.372966938331256	MYH9	1
hsa04024	cAMP signaling pathway	1/22	221/8144	0.454496702968896	0.477080390072941	0.374413759882843	FOS	1
hsa05208	Chemical carcinogenesis - reactive oxygen species	1/22	223/8144	0.457522114060313	0.477291588124647	0.37457950858739	FOS	1
hsa05163	Human cytomegalovirus infection	1/22	225/8144	0.460531504596608	0.47748358452041	0.374730187789297	PRKCA	1
hsa04014	Ras signaling pathway	1/22	232/8144	0.470939372875244	0.485297280584855	0.380862393981263	PRKCA	1
hsa04020	Calcium signaling pathway	1/22	240/8144	0.482599372446911	0.494298751172896	0.387926768282684	PRKCA	1
hsa05020	Prion disease	1/22	273/8144	0.528155152145854	0.537700124774996	0.42198826360417	DDIT3	1
hsa05165	Human papillomavirus infection	1/22	331/8144	0.599097755718886	0.606272579140669	0.475804079549824	RBPJ	1
hsa04080	Neuroactive ligand-receptor interaction	1/22	362/8144	0.632715931697907	0.636482097958013	0.499512577656242	ADM	1
hsa05168	Herpes simplex virus 1 infection	1/22	495/8144	0.748769088429974	0.748769088429974	0.587635659558871	BCL2	1
